PSA – Quo vadis?

摘要: Prostate cancer is the most frequent in males. Because of high cure rates, early detection prostate should identify organ-confined cancers. An examination be performed annually starting at age 50 years and ending when life expectancy less than 10 years. Digital rectal supplemented by determination prostate-specific antigen (PSA). Before first PSA test, patient must informed possible consequences such as biopsy recommendation treatment options. A threshold 4 ng/ml defined indication for biopsy. Imaging methods do not play a major role today. Early identifies many latent cancers, patients may receive overtreatment. solution to change paradigm from all cancers identification aggressive ones. In this article, discussed based on recent literature.